Armistice Capital, LLC — 13F Holdings

2026 Q3  ·  497 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, ARMISTICE CAPITAL, LLC maintained a portfolio of 497 distinct positions. The most significant new addition was TELIX PHARMACEUTICAL LTD, now representing 0.22% of the total fund value. They heavily accumulated shares in ISHARES TR, increasing the position by 13.8%. The fund also reduced its exposure to MADRIGAL PHARMACEUTICALS INC by 68.0%.
Position History hover any row below to update
Loading…
ARMISTICE CAPITAL, LLC New York, NY Hedge Fund AUM $2,982M
PCA Score Concentration Risk
Risk ENB
Total Positions
497
Quarter
2026 Q3
Top Holding
SPY (31.3%)
Top 10 Concentration
64.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 497

ARMISTICE CAPITAL, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
SPY
STATE STR SPDR ...
CALL
CALL Option 31.31% — #1
Prev: #—
9.5
—
3,350,000 —
NEW
3,350,000 $2,554,810,500
$412.97 +76.8%
$762.63 -4.3%
2014 Q4 13F Filing 2026-09-30 2026-11-16
IWM
ISHARES TR
CALL
CALL Option 22.48% — #2
Prev: #—
9.0
—
6,600,000 —
NEW
6,600,000 $1,834,074,000 2019 Q3 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
CALL
CALL Option 2.07% 1.59% #3 1
Prev: #4
4.8
—
1,030,000 67.3%
P
S
2,560,000 $168,729,600 2024 Q1 13F Filing 2026-09-30 2026-11-16
MDGL
MADRIGAL PHARMA...
CALL
CALL Option 1.57% — #4
Prev: #—
4.6
—
255,000 —
NEW
255,000 $128,509,800 2016 Q3 13F Filing 2026-09-30 2026-11-16
AGIO
AGIOS PHARMACEU...
CALL
CALL Option 1.35% 1.28% #5 1
Prev: #6
3.0
—
495,100 17.6%
P
S
3,305,100 $109,894,575 2022 Q3 13F Filing 2026-09-30 2026-11-16
SUPN
SUPERNUS PHARMA...
Healthcare 1.34% 1.51% #6 1
Prev: #5
1.0
—
-98,201 -3.7%
P
S
2,548,000 $109,665,920 2019 Q4 13F Filing 2026-09-30 2026-11-16
PTCT
PTC THERAPEUTIC...
CALL
CALL Option 1.26% 0.66% #7 16
Prev: #23
3.5
—
930,000 140.9%
P
S
1,590,000 $103,000,200 2018 Q4 13F Filing 2026-09-30 2026-11-16
AGIO
AGIOS PHARMACEU...
Healthcare 1.05% 1.09% #8 3
Prev: #11
2.4
—
178,000 7.4%
P
S
2,578,000 $85,718,500 2022 Q3 13F Filing 2026-09-30 2026-11-16
PTCT
PTC THERAPEUTIC...
Healthcare 1.03% 1.07% #9 3
Prev: #12
2.9
—
226,115 21.1%
P
S
1,297,510 $84,052,698 2018 Q4 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 0.98% 1.10% #10 1
Prev: #9
2.4
—
29,413 5.5%
P
S
565,251 $80,175,202 2022 Q1 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 0.95% 1.25% #11 4
Prev: #7
0.9
—
-21,150 -1.8%
P
S
1,180,192 $77,786,455 2024 Q1 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
Healthcare 0.93% 1.09% #12 2
Prev: #10
0.9
—
-282,771 -18.0%
P
S
1,289,768 $75,941,540 2021 Q1 13F Filing 2026-09-30 2026-11-16
RIGL
RIGEL PHARMACEU...
Healthcare 0.91% 0.80% #13 5
Prev: #18
0.9
—
-136,000 -8.1%
P
S
1,536,000 $73,958,400 2024 Q2 13F Filing 2026-09-30 2026-11-16
INCY
INCYTE CORP
Healthcare 0.89% 1.25% #14 6
Prev: #8
0.4
—
-299,960 -33.3%
P
S
600,045 $72,815,461 2017 Q3 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
CALL
CALL Option 0.87% — #15
Prev: #—
3.8
—
500,000 —
NEW
500,000 $70,920,000 2022 Q1 13F Filing 2026-09-30 2026-11-16
IRWD
IRONWOOD PHARMA...
Healthcare 0.73% 0.72% #16 4
Prev: #20
2.3
—
1,068,000 7.7%
P
S
15,000,000 $59,550,000 2023 Q3 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
Healthcare 0.72% 0.82% #17
Prev: #17
0.8
—
2,169 0.1%
P
S
1,738,169 $58,715,349 2023 Q3 13F Filing 2026-09-30 2026-11-16
HRMY
HARMONY BIOSCIE...
Healthcare 0.69% 0.70% #18 3
Prev: #21
0.8
—
-128,000 -8.2%
P
S
1,436,000 $56,377,360 2025 Q4 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
CALL
CALL Option 0.67% 0.57% #19 7
Prev: #26
2.8
—
425,000 35.4%
P
S
1,625,000 $54,892,500 2023 Q3 13F Filing 2026-09-30 2026-11-16
FRPT
FRESHPET INC
Consumer Defensive 0.63% 0.91% #20 6
Prev: #14
0.3
—
-372,008 -29.5%
P
S
888,694 $51,153,227 2015 Q3 13F Filing 2026-09-30 2026-11-16
MDGL
MADRIGAL PHARMA...
Healthcare 0.57% 1.89% #21 18
Prev: #3
0.2
—
-195,976 -68.0%
P
S
92,024 $46,376,415 2016 Q3 13F Filing 2026-09-30 2026-11-16
AMZN
AMAZON COM INC
Consumer Cyclical 0.57% 0.83% #22 6
Prev: #16
0.2
—
-98,735 -34.7%
P
S
185,827 $46,298,797 2017 Q4 13F Filing 2026-09-30 2026-11-16
VSTM
VERASTEM INC
Healthcare 0.56% 0.33% #23 26
Prev: #49
0.7
—
-1,300,000 -18.5%
P
S
5,724,000 $46,078,200 2024 Q3 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
Healthcare 0.54% 0.57% #24 1
Prev: #25
0.7
—
32,000 1.8%
P
S
1,768,000 $44,429,840 2025 Q2 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 0.53% 0.84% #25 10
Prev: #15
0.7
—
-409,166 -13.3%
P
S
2,678,060 $43,143,547 2023 Q2 13F Filing 2026-09-30 2026-11-16
REGN
REGENERON PHARM...
Healthcare 0.53% 0.69% #26 4
Prev: #22
0.2
—
-33,073 -36.8%
P
S
56,736 $43,021,207 2017 Q1 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
CALL
CALL Option 0.52% 0.35% #27 18
Prev: #45
2.7
—
220,000 44.0%
P
S
720,000 $42,393,600 2021 Q1 13F Filing 2026-09-30 2026-11-16
NKTR
NEKTAR THERAPEU...
Healthcare 0.52% 0.62% #28 4
Prev: #24
0.7
—
-24,000 -3.3%
P
S
700,000 $42,381,500 2024 Q2 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
CALL
CALL Option 0.49% 0.34% #29 18
Prev: #47
3.2
—
560,000 53.8%
P
S
1,600,000 $40,208,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
MDB
MONGODB INC
Technology 0.46% 0.51% #30 1
Prev: #31
0.7
—
-16,832 -13.4%
P
S
108,340 $37,768,407 2022 Q3 13F Filing 2026-09-30 2026-11-16
GSK
GSK PLC
Healthcare 0.43% 0.19% #31 43
Prev: #74
3.2
—
424,000 141.3%
P
S
724,000 $34,875,080 2015 Q3 13F Filing 2026-09-30 2026-11-16
IMCR
IMMUNOCORE HLDG...
Healthcare 0.42% 0.55% #32 4
Prev: #28
0.2
—
-292,000 -20.4%
P
S
1,136,000 $34,409,440 2022 Q1 13F Filing 2026-09-30 2026-11-16
ISRG
INTUITIVE SURGI...
Healthcare 0.42% 0.24% #33 32
Prev: #65
3.2
—
35,082 71.9%
P
S
83,886 $34,110,564 2022 Q1 13F Filing 2026-09-30 2026-11-16
OFIX
ORTHOFIX MED IN...
Healthcare 0.42% 0.36% #34 8
Prev: #42
2.2
—
360,000 11.0%
P
S
3,624,000 $34,101,840 2022 Q4 13F Filing 2026-09-30 2026-11-16
SNY
SANOFI SA
Healthcare 0.42% 0.56% #35 8
Prev: #27
0.2
—
-240,000 -22.6%
P
S
824,000 $33,973,520 2016 Q2 13F Filing 2026-09-30 2026-11-16
UBER
UBER TECHNOLOGI...
Technology 0.41% 0.44% #36 2
Prev: #34
0.7
—
-11,259 -2.3%
P
S
486,649 $33,340,323 2020 Q1 13F Filing 2026-09-30 2026-11-16
MSFT
MICROSOFT CORP
Technology 0.41% 0.37% #37 4
Prev: #41
0.7
—
-15,920 -19.8%
P
S
64,661 $33,164,627 2020 Q3 13F Filing 2026-09-30 2026-11-16
UNH
UNITEDHEALTH GR...
Healthcare 0.40% 0.93% #38 25
Prev: #13
0.2
—
-93,000 -50.8%
P
S
90,000 $33,037,200 2019 Q3 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 0.40% 0.41% #39 3
Prev: #36
2.2
—
40,000 8.7%
P
S
500,000 $32,730,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
GOOGL
ALPHABET INC
Communication Services 0.40% 0.55% #40 11
Prev: #29
0.2
—
-31,494 -24.9%
P
S
95,000 $32,687,600 2021 Q3 13F Filing 2026-09-30 2026-11-16
SLDB
SOLID BIOSCIENC...
Healthcare 0.40% 0.52% #41 11
Prev: #30
2.2
—
218,000 5.1%
P
S
4,496,000 $32,506,080 2025 Q2 13F Filing 2026-09-30 2026-11-16
GTLB
GITLAB INC
Technology 0.38% 0.40% #42 5
Prev: #37
0.2
—
-413,437 -38.5%
P
S
660,704 $31,218,264 2025 Q2 13F Filing 2026-09-30 2026-11-16
FIVN
FIVE9 INC
Technology 0.37% 0.40% #43 5
Prev: #38
0.1
—
-660,000 -43.0%
P
S
876,000 $29,792,760 2021 Q4 13F Filing 2026-09-30 2026-11-16
AXGN
AXOGEN INC
Healthcare 0.36% 0.44% #44 9
Prev: #35
0.6
—
-83,000 -10.7%
P
S
692,000 $29,008,640 2024 Q3 13F Filing 2026-09-30 2026-11-16
XRAY
DENTSPLY SIRONA...
Healthcare 0.35% 0.48% #45 12
Prev: #33
0.6
—
-436,000 -11.9%
P
S
3,236,000 $28,670,960 2021 Q3 13F Filing 2026-09-30 2026-11-16
NTLA
INTELLIA THERAP...
Healthcare 0.35% 0.31% #46 5
Prev: #51
3.1
—
864,000 57.6%
P
S
2,364,000 $28,509,840 2025 Q1 13F Filing 2026-09-30 2026-11-16
WYNN
WYNN RESORTS LT...
Consumer Cyclical 0.35% 0.31% #47 5
Prev: #52
2.6
—
95,971 36.8%
P
S
357,036 $28,359,369 2020 Q3 13F Filing 2026-09-30 2026-11-16
TMCI
TREACE MED CONC...
Healthcare 0.35% 0.31% #48 5
Prev: #53
1.1
—
no change no change
P
S
6,364,000 $28,256,160 2023 Q4 13F Filing 2026-09-30 2026-11-16
FDMT
4D MOLECULAR TH...
Healthcare 0.34% 0.33% #49 1
Prev: #50
0.6
—
-50,000 -2.5%
P
S
1,950,000 $27,904,500 2024 Q3 13F Filing 2026-09-30 2026-11-16
BABA
ALIBABA GROUP H...
Consumer Cyclical 0.33% 0.20% #50 21
Prev: #71
2.6
—
82,000 48.8%
P
S
250,000 $26,885,000 2020 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 497 holdings

Unlock Full ARMISTICE CAPITAL, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →